NOS1 and Alzheimer disease: In AD, the three NOS isoforms are suggested to operate as central mediators of amyloid-β (Aβ) action, contributing to the maintenance, self-perpetuation, and progression of the disease [137], although data regarding changes in NOS in AD are highly inconsistent [138].